{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:20:13Z","timestamp":1762561213222,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974387","82373451"],"award-info":[{"award-number":["81974387","82373451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.wneu.2024.11.103","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:14:41Z","timestamp":1734624881000},"page":"123520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identifying Subgroups with Rapid Tumor Growth Rate in Adult Pituitary Neuroendocrine Tumors: A Comprehensive Analysis of Clinical and Imaging Features"],"prefix":"10.1016","volume":"194","author":[{"given":"Zhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6479-7376","authenticated-orcid":false,"given":"Pinan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2024.11.103_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2024.11.103_bib2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2024.11.103_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/cen.14127","article-title":"Current perspectives on recurrent pituitary adenoma: the role and timing of surgery vs adjuvant treatment","volume":"92","author":"Hayhurst","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2024.11.103_bib4","first-page":"1739","article-title":"Challenging Knosp high-grade pituitary adenomas","volume":"132","author":"Micko","year":"2019","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.11.103_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","article-title":"Aggressive pituitary tumours and pituitary carcinomas","volume":"17","author":"Raverot","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.wneu.2024.11.103_bib6","first-page":"803","article-title":"Growth rate of human pituitary adenomas","volume":"67","author":"Landolt","year":"1987","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.11.103_bib7","first-page":"359","article-title":"Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index","volume":"98","author":"Tanaka","year":"2003","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.11.103_bib8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/BF01411125","article-title":"The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas","volume":"138","author":"Ekramullah","year":"1996","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2024.11.103_bib9","first-page":"753","article-title":"Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence","volume":"78","author":"Hsu","year":"1993","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.11.103_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1210\/jc.2013-3054","article-title":"Growth patterns of pituitary adenomas and histopathological correlates","volume":"99","author":"Monsalves","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2024.11.103_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ecl.2020.06.002","article-title":"Advances in the imaging of pituitary tumors","volume":"49","author":"MacFarlane","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.wneu.2024.11.103_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.05.002","article-title":"Modern imaging of pituitary adenomas","volume":"33","author":"Bashari","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2024.11.103_bib13","article-title":"Hardy-wilson classifications for the prediction of surgical outcomes in the endoscopic endonasal surgery of pituitary adenomas: study of 228 cases","volume":"11","author":"Araujo-Castro","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2024.11.103_bib14","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2024.11.103_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0037-1603649","article-title":"Rater reliability of the Hardy classification for pituitary adenomas in the magnetic resonance imaging era","volume":"78","author":"Mooney","year":"2017","journal-title":"J\u00a0Neurol Surg B Skull Base"},{"key":"10.1016\/j.wneu.2024.11.103_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/02688690601000717","article-title":"To assess the ability of MRI to predict consistency of pituitary macroadenomas","volume":"20","author":"Bahuleyan","year":"2006","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.wneu.2024.11.103_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/1078-0432.CCR-13-2098","article-title":"Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials","volume":"20","author":"Ferte","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2024.11.103_bib18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/neuonc\/noab019","article-title":"Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study","volume":"23","author":"Graillon","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.11.103_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/neuonc\/noy137","article-title":"Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.11.103_bib20","first-page":"234","article-title":"Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2024.11.103_bib21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1530\/EJE-09-1100","article-title":"MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma","volume":"162","author":"Hsu","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2024.11.103_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.rxeng.2017.10.006","article-title":"Assessment of the extent of pituitary macroadenomas resection in immediate postoperative MRI","volume":"60","author":"Taberner Lopez","year":"2018","journal-title":"Radiologia (Engl Ed)"},{"key":"10.1016\/j.wneu.2024.11.103_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0090-3019(99)00157-3","article-title":"Postoperative MRI appearance after transsphenoidal pituitary tumor resection","volume":"52","author":"Rajaraman","year":"1999","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2024.11.103_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.wneu.2024.11.103_bib25","first-page":"998","article-title":"Proliferation-dominant high-grade astrocytoma: survival benefit associated with extensive resection of FLAIR abnormality region","volume":"132","author":"Jiang","year":"2020","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2024.11.103_bib26","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/S2214-109X(23)00541-7","article-title":"Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa","volume":"12","author":"Gupta-Wright","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.wneu.2024.11.103_bib27","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/jcsm.12977","article-title":"Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer","volume":"13","author":"Tang","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.wneu.2024.11.103_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0730-725X(91)90012-B","article-title":"The use of T2 distribution to study tumor extent and heterogeneity in head and neck cancer","volume":"9","author":"Bloch","year":"1991","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.wneu.2024.11.103_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00381-017-3659-8","article-title":"T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity","volume":"34","author":"Harward","year":"2018","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.wneu.2024.11.103_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12905-019-0769-3","article-title":"Mammography and MRI manifestations of breast angiosarcoma","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Wom Health"},{"key":"10.1016\/j.wneu.2024.11.103_bib31","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41388-019-1128-4","article-title":"Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence","volume":"39","author":"Vessoni","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2024.11.103_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semcancer.2020.12.002","article-title":"Metabolic regulation of prostate cancer heterogeneity and plasticity","volume":"82","author":"Peitzsch","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.wneu.2024.11.103_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00330-004-2531-x","article-title":"Magnetic resonance imaging of pituitary adenomas","volume":"15","author":"Bonneville","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1016\/j.wneu.2024.11.103_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11102-018-0928-9","article-title":"A\u00a0plea for the T2W MR sequence for pituitary imaging","volume":"22","author":"Bonneville","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2024.11.103_bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/cen.12443","article-title":"Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas","volume":"81","author":"Cazabat","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2024.11.103_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11102-017-0788-8","article-title":"T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective","volume":"20","author":"Potorac","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2024.11.103_bib37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrendo.2014.64","article-title":"Aggressive pituitary adenomas--diagnosis and emerging treatments","volume":"10","author":"Di Ieva","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.wneu.2024.11.103_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024019673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875024019673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:17:27Z","timestamp":1762561047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875024019673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":38,"alternative-id":["S1878875024019673"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2024.11.103","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying Subgroups with Rapid Tumor Growth Rate in Adult Pituitary Neuroendocrine Tumors: A Comprehensive Analysis of Clinical and Imaging Features","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2024.11.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123520"}}